Curcumin-Based Fixed Dose Combination Products for Cholesterol Management: A Narrative Review.

Area of Science:

• Pharmacology
• Biochemistry
• Nutraceuticals

Background:

• Curcumin, a polyphenol from curcuminoids, interacts with biological macromolecules.
• Curcumin-based fixed-dose combination (FDC) products improve curcumin's stability and bioavailability.
• Preclinical research indicates positive effects of curcumin on cholesterol levels.

Purpose of the Study:

• To evaluate the potential of curcumin-based FDC products in cholesterol management.
• To identify challenges and opportunities for clinical application of curcumin in lipid control.

Main Methods:

• Review of preclinical studies on curcumin and cholesterol.
• Analysis of existing randomized controlled trials (RCTs) for curcumin-based FDC products.
• Identification of limitations in current research and product standardization.

Main Results:

• Preclinical data suggests curcumin's efficacy in cholesterol management.
• Significant variability in FDC product composition and lack of standardized formulations pose challenges.
• Limited RCTs exist for specific curcumin products, hindering definitive clinical conclusions.

Conclusions:

• Curcumin-based FDC products hold significant potential for cholesterol management.
• Addressing issues of product standardization and conducting rigorous RCTs is crucial.
• These products may offer adjunct therapy to statins, potentially reducing dosages or serving as alternatives.